aluates Reports

$ 0.0

Automative

Artemisinin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-18I5386

Global Artemisinin API Market Insights and Forecast to 2028

BUY CHAPTERS

Artemisinin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18I5386

Report

October 2024

Pages:133

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

KPC Pharmaceuticals

Kerui nanhai

Guangxi xiancaotang

Guilin Pharmaceutical

Natural Bio-engineering

BIONEXX

CAT KHANH

BEEPZ

Novanat Bioresource

Artemisinin API - Market Size

The global market for Artemisinin API was estimated to be worth US$ 763 million in 2023 and is forecast to a readjusted size of US$ 1256.8 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030

Artemisinin API - Market

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artemisinin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artemisinin API by region & country, by Type, and by Application.

The Artemisinin API market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin API.

Market Segmentation

Scope of Artemisinin API - Market Report

Report Metric	Details
Report Name	Artemisinin API - Market
Forecasted market size in 2030	US$ 1256.8 million
CAGR	8.0%
Forecasted years	2024 - 2030
Segment by Type:	Extraction from Artemisia annua Semisynthetic Artemisinin
Segment by Application	Antimalarial Injections Antimalarial Tablets
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, KPC Pharmaceuticals, Kerui nanhai, Guangxi xiancaotang, Guilin Pharmaceutical, Natural Bio-engineering, BIONEXX, CAT KHANH, BEEPZ, Novanat Bioresource
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artemisinin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Artemisinin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Artemisinin API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Artemisinin API - Market size in 2030?

Ans: The Artemisinin API - Market size in 2030 will be US$ 1256.8 million.

Who are the main players in the Artemisinin API - Market report?

Ans: The main players in the Artemisinin API - Market are Sanofi, KPC Pharmaceuticals, Kerui nanhai, Guangxi xiancaotang, Guilin Pharmaceutical, Natural Bio-engineering, BIONEXX, CAT KHANH, BEEPZ, Novanat Bioresource

What are the Application segmentation covered in the Artemisinin API - Market report?

Ans: The Applications covered in the Artemisinin API - Market report are Antimalarial Injections, Antimalarial Tablets

What are the Type segmentation covered in the Artemisinin API - Market report?

Ans: The Types covered in the Artemisinin API - Market report are Extraction from Artemisia annua, Semisynthetic Artemisinin

Recommended Reports

API Market Reports

Antimalarial & Antibiotics

Specialty & Herbals

1 Market Overview

1.1 Artemisinin API Product Introduction

1.2 Global Artemisinin API Market Size Forecast

1.2.1 Global Artemisinin API Sales Value (2019-2030)

1.2.2 Global Artemisinin API Sales Volume (2019-2030)

1.2.3 Global Artemisinin API Sales Price (2019-2030)

1.3 Artemisinin API Market Trends & Drivers

1.3.1 Artemisinin API Industry Trends

1.3.2 Artemisinin API Market Drivers & Opportunity

1.3.3 Artemisinin API Market Challenges

1.3.4 Artemisinin API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Artemisinin API Players Revenue Ranking (2023)

2.2 Global Artemisinin API Revenue by Company (2019-2024)

2.3 Global Artemisinin API Players Sales Volume Ranking (2023)

2.4 Global Artemisinin API Sales Volume by Company Players (2019-2024)

2.5 Global Artemisinin API Average Price by Company (2019-2024)

2.6 Key Manufacturers Artemisinin API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Artemisinin API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Artemisinin API

2.9 Artemisinin API Market Competitive Analysis

2.9.1 Artemisinin API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Artemisinin API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Extraction from Artemisia annua

3.1.2 Semisynthetic Artemisinin

3.2 Global Artemisinin API Sales Value by Type

3.2.1 Global Artemisinin API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Artemisinin API Sales Value, by Type (2019-2030)

3.2.3 Global Artemisinin API Sales Value, by Type (%) (2019-2030)

3.3 Global Artemisinin API Sales Volume by Type

3.3.1 Global Artemisinin API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Artemisinin API Sales Volume, by Type (2019-2030)

3.3.3 Global Artemisinin API Sales Volume, by Type (%) (2019-2030)

3.4 Global Artemisinin API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Antimalarial Injections

4.1.2 Antimalarial Tablets

4.2 Global Artemisinin API Sales Value by Application

4.2.1 Global Artemisinin API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Artemisinin API Sales Value, by Application (2019-2030)

4.2.3 Global Artemisinin API Sales Value, by Application (%) (2019-2030)

4.3 Global Artemisinin API Sales Volume by Application

4.3.1 Global Artemisinin API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Artemisinin API Sales Volume, by Application (2019-2030)

4.3.3 Global Artemisinin API Sales Volume, by Application (%) (2019-2030)

4.4 Global Artemisinin API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Artemisinin API Sales Value by Region

5.1.1 Global Artemisinin API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Artemisinin API Sales Value by Region (2019-2024)

5.1.3 Global Artemisinin API Sales Value by Region (2025-2030)

5.1.4 Global Artemisinin API Sales Value by Region (%), (2019-2030)

5.2 Global Artemisinin API Sales Volume by Region

5.2.1 Global Artemisinin API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Artemisinin API Sales Volume by Region (2019-2024)

5.2.3 Global Artemisinin API Sales Volume by Region (2025-2030)

5.2.4 Global Artemisinin API Sales Volume by Region (%), (2019-2030)

5.3 Global Artemisinin API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Artemisinin API Sales Value, 2019-2030

5.4.2 North America Artemisinin API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Artemisinin API Sales Value, 2019-2030

5.5.2 Europe Artemisinin API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Artemisinin API Sales Value, 2019-2030

5.6.2 Asia Pacific Artemisinin API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Artemisinin API Sales Value, 2019-2030

5.7.2 South America Artemisinin API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Artemisinin API Sales Value, 2019-2030

5.8.2 Middle East & Africa Artemisinin API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Artemisinin API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Artemisinin API Sales Value

6.2.1 Key Countries/Regions Artemisinin API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Artemisinin API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Artemisinin API Sales Value, 2019-2030

6.3.2 United States Artemisinin API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Artemisinin API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Artemisinin API Sales Value, 2019-2030

6.4.2 Europe Artemisinin API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Artemisinin API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Artemisinin API Sales Value, 2019-2030

6.5.2 China Artemisinin API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Artemisinin API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Artemisinin API Sales Value, 2019-2030

6.6.2 Japan Artemisinin API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Artemisinin API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Artemisinin API Sales Value, 2019-2030

6.7.2 South Korea Artemisinin API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Artemisinin API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Artemisinin API Sales Value, 2019-2030

6.8.2 Southeast Asia Artemisinin API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Artemisinin API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Artemisinin API Sales Value, 2019-2030

6.9.2 India Artemisinin API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Artemisinin API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi

7.1.1 Sanofi Company Information

7.1.2 Sanofi Introduction and Business Overview

7.1.3 Sanofi Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Artemisinin API Product Offerings

7.1.5 Sanofi Recent Development

7.2 KPC Pharmaceuticals

7.2.1 KPC Pharmaceuticals Company Information

7.2.2 KPC Pharmaceuticals Introduction and Business Overview

7.2.3 KPC Pharmaceuticals Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 KPC Pharmaceuticals Artemisinin API Product Offerings

7.2.5 KPC Pharmaceuticals Recent Development

7.3 Kerui nanhai

7.3.1 Kerui nanhai Company Information

7.3.2 Kerui nanhai Introduction and Business Overview

7.3.3 Kerui nanhai Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Kerui nanhai Artemisinin API Product Offerings

7.3.5 Kerui nanhai Recent Development

7.4 Guangxi xiancaotang

7.4.1 Guangxi xiancaotang Company Information

7.4.2 Guangxi xiancaotang Introduction and Business Overview

7.4.3 Guangxi xiancaotang Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Guangxi xiancaotang Artemisinin API Product Offerings

7.4.5 Guangxi xiancaotang Recent Development

7.5 Guilin Pharmaceutical

7.5.1 Guilin Pharmaceutical Company Information

7.5.2 Guilin Pharmaceutical Introduction and Business Overview

7.5.3 Guilin Pharmaceutical Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Guilin Pharmaceutical Artemisinin API Product Offerings

7.5.5 Guilin Pharmaceutical Recent Development

7.6 Natural Bio-engineering

7.6.1 Natural Bio-engineering Company Information

7.6.2 Natural Bio-engineering Introduction and Business Overview

7.6.3 Natural Bio-engineering Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Natural Bio-engineering Artemisinin API Product Offerings

7.6.5 Natural Bio-engineering Recent Development

7.7 BIONEXX

7.7.1 BIONEXX Company Information

7.7.2 BIONEXX Introduction and Business Overview

7.7.3 BIONEXX Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 BIONEXX Artemisinin API Product Offerings

7.7.5 BIONEXX Recent Development

7.8 CAT KHANH

7.8.1 CAT KHANH Company Information

7.8.2 CAT KHANH Introduction and Business Overview

7.8.3 CAT KHANH Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 CAT KHANH Artemisinin API Product Offerings

7.8.5 CAT KHANH Recent Development

7.9 BEEPZ

7.9.1 BEEPZ Company Information

7.9.2 BEEPZ Introduction and Business Overview

7.9.3 BEEPZ Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 BEEPZ Artemisinin API Product Offerings

7.9.5 BEEPZ Recent Development

7.10 Novanat Bioresource

7.10.1 Novanat Bioresource Company Information

7.10.2 Novanat Bioresource Introduction and Business Overview

7.10.3 Novanat Bioresource Artemisinin API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Novanat Bioresource Artemisinin API Product Offerings

7.10.5 Novanat Bioresource Recent Development

8 Industry Chain Analysis

8.1 Artemisinin API Industrial Chain

8.2 Artemisinin API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Artemisinin API Sales Model

8.5.2 Sales Channel

8.5.3 Artemisinin API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi

KPC Pharmaceuticals

Kerui nanhai

Guangxi xiancaotang

Guilin Pharmaceutical

Natural Bio-engineering

BIONEXX

CAT KHANH

BEEPZ

Novanat Bioresource

List of Tables

Table 1. Artemisinin API Market Trends

Table 2. Artemisinin API Market Drivers & Opportunity

Table 3. Artemisinin API Market Challenges

Table 4. Artemisinin API Market Restraints

Table 5. Global Artemisinin API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Artemisinin API Revenue Market Share by Company (2019-2024)

Table 7. Global Artemisinin API Sales Volume by Company (2019-2024) & (Kiloton)

Table 8. Global Artemisinin API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Artemisinin API Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Artemisinin API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Artemisinin API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Artemisinin API

Table 13. Global Artemisinin API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Artemisinin API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Artemisinin API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Artemisinin API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Artemisinin API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Artemisinin API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Artemisinin API Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)

Table 22. Global Artemisinin API Sales Volume by Type (2019-2024) & (Kiloton)

Table 23. Global Artemisinin API Sales Volume by Type (2025-2030) & (Kiloton)

Table 24. Global Artemisinin API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Artemisinin API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Artemisinin API Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Artemisinin API Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Artemisinin API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Artemisinin API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Artemisinin API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Artemisinin API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Artemisinin API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Artemisinin API Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)

Table 34. Global Artemisinin API Sales Volume by Application (2019-2024) & (Kiloton)

Table 35. Global Artemisinin API Sales Volume by Application (2025-2030) & (Kiloton)

Table 36. Global Artemisinin API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Artemisinin API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Artemisinin API Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Artemisinin API Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Artemisinin API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Artemisinin API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Artemisinin API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Artemisinin API Sales Value by Region (2019-2024) & (%)

Table 44. Global Artemisinin API Sales Value by Region (2025-2030) & (%)

Table 45. Global Artemisinin API Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030

Table 46. Global Artemisinin API Sales Volume by Region (2019-2024) & (Kiloton)

Table 47. Global Artemisinin API Sales Volume by Region (2025-2030) & (Kiloton)

Table 48. Global Artemisinin API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Artemisinin API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Artemisinin API Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Artemisinin API Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Artemisinin API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Artemisinin API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Artemisinin API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Artemisinin API Sales Volume, (2019-2024) & (Kiloton)

Table 56. Key Countries/Regions Artemisinin API Sales Volume, (2025-2030) & (Kiloton)

Table 57. Sanofi Company Information

Table 58. Sanofi Introduction and Business Overview

Table 59. Sanofi Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Sanofi Artemisinin API Product Offerings

Table 61. Sanofi Recent Development

Table 62. KPC Pharmaceuticals Company Information

Table 63. KPC Pharmaceuticals Introduction and Business Overview

Table 64. KPC Pharmaceuticals Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. KPC Pharmaceuticals Artemisinin API Product Offerings

Table 66. KPC Pharmaceuticals Recent Development

Table 67. Kerui nanhai Company Information

Table 68. Kerui nanhai Introduction and Business Overview

Table 69. Kerui nanhai Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Kerui nanhai Artemisinin API Product Offerings

Table 71. Kerui nanhai Recent Development

Table 72. Guangxi xiancaotang Company Information

Table 73. Guangxi xiancaotang Introduction and Business Overview

Table 74. Guangxi xiancaotang Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Guangxi xiancaotang Artemisinin API Product Offerings

Table 76. Guangxi xiancaotang Recent Development

Table 77. Guilin Pharmaceutical Company Information

Table 78. Guilin Pharmaceutical Introduction and Business Overview

Table 79. Guilin Pharmaceutical Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Guilin Pharmaceutical Artemisinin API Product Offerings

Table 81. Guilin Pharmaceutical Recent Development

Table 82. Natural Bio-engineering Company Information

Table 83. Natural Bio-engineering Introduction and Business Overview

Table 84. Natural Bio-engineering Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Natural Bio-engineering Artemisinin API Product Offerings

Table 86. Natural Bio-engineering Recent Development

Table 87. BIONEXX Company Information

Table 88. BIONEXX Introduction and Business Overview

Table 89. BIONEXX Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. BIONEXX Artemisinin API Product Offerings

Table 91. BIONEXX Recent Development

Table 92. CAT KHANH Company Information

Table 93. CAT KHANH Introduction and Business Overview

Table 94. CAT KHANH Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. CAT KHANH Artemisinin API Product Offerings

Table 96. CAT KHANH Recent Development

Table 97. BEEPZ Company Information

Table 98. BEEPZ Introduction and Business Overview

Table 99. BEEPZ Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. BEEPZ Artemisinin API Product Offerings

Table 101. BEEPZ Recent Development

Table 102. Novanat Bioresource Company Information

Table 103. Novanat Bioresource Introduction and Business Overview

Table 104. Novanat Bioresource Artemisinin API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 105. Novanat Bioresource Artemisinin API Product Offerings

Table 106. Novanat Bioresource Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Artemisinin API Downstream Customers

Table 110. Artemisinin API Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Artemisinin API Product Picture

Figure 2. Global Artemisinin API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Artemisinin API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Artemisinin API Sales Volume (2019-2030) & (Kiloton)

Figure 5. Global Artemisinin API Sales Price (2019-2030) & (US$/Ton)

Figure 6. Artemisinin API Report Years Considered

Figure 7. Global Artemisinin API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Artemisinin API Players Sales Volume Ranking (2023) & (Kiloton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Artemisinin API Revenue in 2023

Figure 10. Artemisinin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Extraction from Artemisia annua Picture

Figure 12. Semisynthetic Artemisinin Picture

Figure 13. Global Artemisinin API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Artemisinin API Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Artemisinin API Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)

Figure 16. Global Artemisinin API Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Artemisinin API Price by Type (2019-2030) & (US$/Ton)

Figure 18. Product Picture of Antimalarial Injections

Figure 19. Product Picture of Antimalarial Tablets

Figure 20. Global Artemisinin API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Artemisinin API Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Artemisinin API Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)

Figure 23. Global Artemisinin API Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Artemisinin API Price by Application (2019-2030) & (US$/Ton)

Figure 25. North America Artemisinin API Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Artemisinin API Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Artemisinin API Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Artemisinin API Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Artemisinin API Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Artemisinin API Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Artemisinin API Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Artemisinin API Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Artemisinin API Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Artemisinin API Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Artemisinin API Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Artemisinin API Sales Volume (%), (2019-2030)

Figure 37. United States Artemisinin API Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Artemisinin API Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Artemisinin API Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Artemisinin API Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Artemisinin API Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Artemisinin API Sales Value by Application (%), 2023 VS 2030

Figure 43. China Artemisinin API Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Artemisinin API Sales Value by Type (%), 2023 VS 2030

Figure 45. China Artemisinin API Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Artemisinin API Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Artemisinin API Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Artemisinin API Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Artemisinin API Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Artemisinin API Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Artemisinin API Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Artemisinin API Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Artemisinin API Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Artemisinin API Sales Value by Application (%), 2023 VS 2030

Figure 55. India Artemisinin API Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Artemisinin API Sales Value by Type (%), 2023 VS 2030

Figure 57. India Artemisinin API Sales Value by Application (%), 2023 VS 2030

Figure 58. Artemisinin API Industrial Chain

Figure 59. Artemisinin API Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Artemisinin and Its Semisynthetic Aerivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artemisinin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Artemisinic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artemisinin Combination Therapy Market Insights Forecast to 2030

Global Oral Artemether Drugs Market Research Report 2024

Artemisinin Antimalarial Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artesunate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artesunate Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artemether Market Research Report 2025

Artesunate Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artesunate Market Research Report 2024

Global Dihydroartemisinin Tablets Market Research Report 2024

Artesunate Used for Malaria Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artesunate API Market Research Report 2025

Global Artesunate Tablet Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Permethrin Market Research Report 2025

Global Artemether API Market Research Report 2025

Global High end Antibiotic Raw Materials Market Research Report 2024

Global Nystatin API Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions